(2023). Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis. Health Technol Assess, 27, 1-140. http://doi.org/10.3310/ctmd0148.
(2022). Cardiovascular outcomes and mortality after incident ischaemic stroke in patients with a recent cancer history. Eur J Intern Med. http://doi.org/10.1016/j.ejim.2022.12.006.
(2022). Identifying Patients with Bicuspid Aortic Valve Disease in UK Primary Care: A Case-Control Study and Prediction Model. J Pers Med, 12. http://doi.org/10.3390/jpm12081290.
(2022). Comparison of risk of serious cardiovascular events after haemorrhagic versus ischaemic stroke: a population-based study. Thromb Haemost. http://doi.org/10.1055/a-1873-9092.
(2022). Ethnic disparities in mortality among overweight or obese adults with newly diagnosed type 2 diabetes: a population-based cohort study. J Endocrinol Invest. http://doi.org/10.1007/s40618-021-01736-9.
(2015). The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment. Open Heart. http://doi.org/10.1136/openhrt-2015-000272.
(2015). Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT). Atherosclerosis. http://doi.org/10.1016/j.atherosclerosis.2014.12.034.
(2017). Venous thromboembolism in adults screened for sickle cell trait: a population-based cohort study with nested case-control analysis. BMJ Open. http://doi.org/10.1136/bmjopen-2016-012665.
(2017). Can machine-learning improve cardiovascular risk prediction using routine clinical data?. PLoS One. http://doi.org/10.1371/journal.pone.0174944.
(2019). Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease. Heart. http://doi.org/10.1136/heartjnl-2018-314253.